Affymetrix Stock Price, News & Analysis (NASDAQ:AFFX)

$14.01 0.02 (0.14 %)
(As of 11/20/2017 04:12 AM ET)
Previous Close$13.99
Today's Range$14.00 - $14.05
52-Week Range$8.28 - $16.15
Volume5.03 million shs
Average Volume3.49 million shs
Market Capitalization$1.13 billion
P/E RatioN/A
Dividend YieldN/A

About Affymetrix (NASDAQ:AFFX)

Affymetrix logoAffymetrix, Inc. (Affymetrix) is a provider of life science products and molecular diagnostic products that enable parallel analysis of biological systems at the gene, protein and cell level. The Company operates through two business segments: Affymetrix Core and eBioscience. The Affymetrix Core segment focuses on the development, manufacture and commercialization of systems for genetic analysis in the life sciences, agricultural biotechnology (AgBio) and diagnostic industry. The eBioscience segment primarily focuses on the development, manufacture, marketing and distribution of research products in the areas of flow cytometry, immunoassays, microscopic imaging and other protein-based analyses. The Company sells its products to genomic research centers, academic institutions, government and private laboratories, as well as pharmaceutical, diagnostic and biotechnology companies. It maintains sales and distribution operations across the United States, Europe, Latin America and Asia.

Industry, Sector and Symbol:
  • Industry: Bio Diagnostics & Testing
  • Sub-Industry: Life Sciences Tools & Services
  • Sector: N/A
  • Symbol: NASDAQ:AFFX
  • CUSIP: 00826T10
  • Web:
  • Trailing EPS: $0.12
  • Net Margins: 4.24%
  • Return on Equity: 4.84%
  • Return on Assets: 2.97%
  • Outstanding Shares: 80,490,000

Frequently Asked Questions for Affymetrix (NASDAQ:AFFX)

What is Affymetrix's stock symbol?

Affymetrix trades on the NASDAQ under the ticker symbol "AFFX."

How were Affymetrix's earnings last quarter?

Affymetrix, Inc. (NASDAQ:AFFX) announced its quarterly earnings data on Wednesday, February, 17th. The scientific and technical instruments company reported $0.09 EPS for the quarter, missing the consensus estimate of $0.11 by $0.02. The scientific and technical instruments company had revenue of $95.60 million for the quarter, compared to the consensus estimate of $93.29 million. Affymetrix had a net margin of 4.24% and a return on equity of 4.84%. During the same quarter last year, the company posted $0.09 earnings per share. View Affymetrix's Earnings History.

Who are some of Affymetrix's key competitors?

How do I buy Affymetrix stock?

Shares of Affymetrix can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Affymetrix's stock price today?

One share of Affymetrix stock can currently be purchased for approximately $14.01.

How big of a company is Affymetrix?

Affymetrix has a market capitalization of $1.13 billion.

How can I contact Affymetrix?

Affymetrix's mailing address is 3420 Central Expy, SANTA CLARA, CA 95051-0703, United States. The scientific and technical instruments company can be reached via phone at +1-408-7315000.

MarketBeat Community Rating for Affymetrix (NASDAQ AFFX)

Community Ranking:  1.6 out of 5 (star)
Outperform Votes:  98 (Vote Outperform)
Underperform Votes:  207 (Vote Underperform)
Total Votes:  305
MarketBeat's community ratings are surveys of what our community members think about Affymetrix and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Analysts' Consensus Rating for Affymetrix (NASDAQ:AFFX)

  (How are Consensus Ratings Calculated?)
Ratings Breakdown: 0 Sell Ratings, 0 Hold Ratings, 0 Buy Ratings, 0 Strong Buy RatingsNo ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Analysts' Consensus Price Target: N/A

Consensus Price Target History for Affymetrix (NASDAQ:AFFX)

Price Target History for Affymetrix (NASDAQ:AFFX)

Analysts' Ratings History for Affymetrix (NASDAQ:AFFX)

DateFirmActionRatingPrice TargetImpact on Share PriceDetails
4/3/2016Cantor FitzgeraldReiterated RatingHold$14.00N/AView Rating Details
3/23/2016BTIG ResearchReiterated RatingNeutralN/AView Rating Details
2/18/2016Cowen and CompanyBoost Price TargetMarket Perform$10.00 -> $14.00N/AView Rating Details
1/11/2016MizuhoDowngradeBuy -> Neutral$14.00N/AView Rating Details
(Data available from 11/20/2015 forward)


Earnings History and Estimates Chart for Affymetrix (NASDAQ:AFFX)

Earnings by Quarter for Affymetrix (NASDAQ:AFFX)

Earnings History by Quarter for Affymetrix (NASDAQ AFFX)

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/17/2016Q415$0.11$0.09$93.29 million$95.60 millionViewN/AView Earnings Details
10/28/2015Q315$0.08$0.10$88.04 million$86.50 millionViewListenView Earnings Details
7/29/2015Q215$0.07$0.12$88.61 million$89.00 millionViewListenView Earnings Details
4/29/2015Q115$0.04$0.10$87.30 million$88.70 millionViewListenView Earnings Details
2/4/2015Q414$0.07$0.09$91.80 million$93.50 millionViewListenView Earnings Details
10/30/2014Q314$0.04$0.08$84.40 million$87.10 millionViewListenView Earnings Details
7/31/2014Q214$0.03$0.07$83.30 million$85.40 millionViewListenView Earnings Details
5/1/2014Q114$0.02$0.03$81.10 million$83.00 millionViewListenView Earnings Details
2/5/2014Q413$0.07$0.02$89.98 million$92.60 millionViewListenView Earnings Details
7/31/2013Q2 2013($0.01)$0.04$78.53 million$79.46 millionViewListenView Earnings Details
4/30/2013Q1 2013($0.02)($0.01)$78.04 million$77.90 millionViewListenView Earnings Details
1/31/2013Q4 2012($0.03)($0.02)$84.06 million$84.40 millionViewListenView Earnings Details
11/5/2012Q312($0.03)($0.03)$84.56 million$79.60 millionViewN/AView Earnings Details
7/31/2012($0.08)($0.02)ViewN/AView Earnings Details
5/3/2012($0.10)($0.06)ViewN/AView Earnings Details
11/2/2011($0.04)($0.10)ViewN/AView Earnings Details
7/27/2011($0.04)($0.05)ViewN/AView Earnings Details
2/2/2011$0.02$0.06ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Affymetrix (NASDAQ:AFFX)

No earnings estimates for this company have been tracked by


Dividend History for Affymetrix (NASDAQ:AFFX)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading and Institutional Ownership History for Affymetrix (NASDAQ AFFX)

Insider Trades by Quarter for Affymetrix (NASDAQ:AFFX)
Insider Trades by Quarter for Affymetrix (NASDAQ:AFFX)

Insider Trades by Quarter for Affymetrix (NASDAQ AFFX)

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/15/2015Robert H TriceDirectorSell2,500$9.40$23,500.00View SEC Filing  
11/17/2015Robert H TriceDirectorSell2,500$9.00$22,500.00View SEC Filing  
10/15/2015Robert H TriceDirectorSell2,500$9.00$22,500.00View SEC Filing  
7/20/2015Frank WitneyCEOSell37,991$11.20$425,499.20View SEC Filing  
7/10/2015Frank WitneyCEOSell62,756$11.00$690,316.00View SEC Filing  
6/26/2015Frank WitneyCEOSell75,000$11.22$841,500.00View SEC Filing  
6/22/2015David A WeberEVPSell33,879$12.00$406,548.00View SEC Filing  
6/19/2015David A WeberEVPSell14,760$12.00$177,120.00View SEC Filing  
6/4/2015Frank WitneyCEOSell75,000$11.78$883,500.00View SEC Filing  
2/17/2015Gavin WoodCFOSell1,300$11.40$14,820.00View SEC Filing  
1/20/2015Gavin WoodCFOSell22,500$11.77$264,825.00View SEC Filing  
1/12/2015Gavin WoodCFOSell10,200$10.77$109,854.00View SEC Filing  
12/29/2014Gavin WoodCFOSell18,734$10.20$191,086.80View SEC Filing  
11/19/2013Robert TriceDirectorSell6,205$7.98$49,515.90View SEC Filing  
8/21/2012Timothy C BarabeCFOBuy10,000$3.75$37,500.00View SEC Filing  
8/17/2012Timothy C BarabeCFOBuy5,550$3.99$22,144.50View SEC Filing  
8/13/2012Timothy C BarabeCFOBuy4,450$3.99$17,755.50View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Affymetrix (NASDAQ AFFX)

Analyzing Lion Biotechnologies (IOVA) & Affymetrix (AFFX)Analyzing Lion Biotechnologies (IOVA) & Affymetrix (AFFX) - November 19 at 5:06 PM
Comparing Invitae Corporation (NVTA) and Affymetrix (AFFX)Comparing Invitae Corporation (NVTA) and Affymetrix (AFFX) - November 18 at 1:32 PM
CareDx (CDNA) versus Affymetrix (AFFX) Financial AnalysisCareDx (CDNA) versus Affymetrix (AFFX) Financial Analysis - October 28 at 11:42 AM
Contrasting CareDx (CDNA) and Affymetrix (AFFX)Contrasting CareDx (CDNA) and Affymetrix (AFFX) - October 27 at 3:06 AM
Head-To-Head Analysis: Affymetrix (AFFX) vs. CareDx (CDNA)Head-To-Head Analysis: Affymetrix (AFFX) vs. CareDx (CDNA) - September 30 at 6:26 AM
Luminex Partners Sutter Health to Boost Molecular TestingLuminex Partners Sutter Health to Boost Molecular Testing - August 30 at 3:44 PM
Veracyte (VCYT) and Affymetrix (AFFX) Financial ContrastVeracyte (VCYT) and Affymetrix (AFFX) Financial Contrast - August 24 at 4:24 PM
DIGILITI MONEY (DGLT) & Affymetrix (AFFX) Critical SurveyDIGILITI MONEY (DGLT) & Affymetrix (AFFX) Critical Survey - July 14 at 12:54 PM
Form N-PX CAPSTONE SERIES FUND For: Jun 30 - StreetInsider.comForm N-PX CAPSTONE SERIES FUND For: Jun 30 - - July 29 at 3:20 PM
Larry Robbins Largest –st-Quarter SalesLarry Robbins' Largest –st-Quarter Sales - June 10 at 9:01 PM
Thermo Fisher Demonstrates Impressive QuarterThermo Fisher Demonstrates Impressive Quarter - April 28 at 10:42 AM
Affymetrix (AFFX) Stock Retreats After Origin Withdraws Takeover BidAffymetrix (AFFX) Stock Retreats After Origin Withdraws Takeover Bid - March 29 at 9:55 AM

Social Media



Affymetrix (NASDAQ AFFX) Chart for Monday, November, 20, 2017
Loading chart…

This page was last updated on 11/20/2017 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.